DNL921 clinical trials

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease

This study is looking at a new potential medicine, DNL921, for Alzheimer's disease. Researchers want to see if it's safe, how the body handles it, and how it affects the body. They're testing it in healthy people and those with early Alzheimer's.